Kijimea

Discover leading scientific probiotics from Kijimea.

Kijimea is a European probiotics brand guided by the principle “Proven by research. Designed for life”. Founded in 2011 and led by FUTRUE founders Dr. Clemens Fischer and Madlena Hohlefelder, the brand was created from a belief that microbiome science deserves more attention in everyday life. Kijimea works with microbiome researchers and scientific institutions internationally, including Charité in Berlin, and places emphasis on high quality study designs such as randomised, double-blind, placebo-controlled research.

Kijimea’s direction was shaped by growing scientific interest in the microbiome following milestones such as Professor Joshua Lederberg’s coining of the term “microbiome”, and large-scale initiatives like the Human Microbiome Project. Kijimea’s early work included the discovery and development of the patented bacterial strain B. bifidum MIMBb75, which became a cornerstone of its portfolio.

Over time, the range of Kijimea probiotics has expanded alongside advances in microbiome understanding, with products developed for different areas of wellbeing, including women’s health, skin and the gut-brain axis. One of its broad-spectrum offerings, Kijimea K53 Advance, is positioned around bacterial diversity, designed to reflect the variety found in the natural gut microbiome.

Kijimea continues to translate evolving microbiome research into carefully developed probiotic products, reflecting its ongoing commitment to scientific rigour, collaboration and evidence-led innovation. As a UK stockist of Kijimea probiotics, browse the selection at Healf.